In the BioHarmony Drug Report Database

"Preview" Icon

Tipiracil

Lonsurf (tipiracil) is a small molecule pharmaceutical. Tipiracil was first approved as Lonsurf on 2015-09-22. It is used to treat colorectal neoplasms in the USA. It has been approved in Europe to treat colorectal neoplasms. Lonsurf’s patents are valid until 2037-02-03 (FDA).

 

Trade Name

 

Lonsurf
 

Common Name

 

tipiracil
 

ChEMBL ID

 

CHEMBL235668
 

Indication

 

colorectal neoplasms
 

Drug Class

 

Uracil type antineoplastics

Image (chem structure or protein)

Tipiracil structure rendering